Exane Derivatives’s Synchronoss Technologies SNCR Stock Holding History

Exane Derivatives’s Portfolio SNCR Stock Details SNCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,086	Closed	-$291K	–	702
2018 Q1	$291K	Sell	3,086 -556	-15%	-$45.6K	0.06%	206
2017 Q4	$293K	Buy	3,642 +626	+21%	+$60.5K	0.05%	205
2017 Q3	$253K	Buy	3,016 +755	+33%	+$105K	0.05%	187
2017 Q2	$335K	Buy	+2,261	New	+$337K	0.07%	165
2015 Q4	–	Sell	-23	Closed	-$6.66K	–	558
2015 Q3	$6.66K	Sell	23 -113	-83%	-$43.8K	﹤0.01%	374
2015 Q2	$55.8K	Buy	+136	New	+$58.5K	0.01%	282

Other funds holding SNCR

CPA

Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

DTL

Dynamic Technology Lab Singapore $615M AUM 11.3% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return

Exane Derivatives's SNCR Position: Q2 2018 in Review

Exane Derivatives sold out of Synchronoss Technologies (SNCR) in Q2 2018, closing a stake of 3,086 shares — an estimated $291K sold.

Exane Derivatives first reported a position in SNCR in Q2 2015 and held it in 6 quarters. The position peaked at $335K in Q2 2017. 26 funds tracked by Wall St. Rank hold SNCR as of Q2 2018.

Exane Derivatives reported no remaining Synchronoss Technologies position as of Q2 2018 after selling out during the quarter.
Exane Derivatives sold 3,086 Synchronoss Technologies shares in Q2 2018, an estimated $291K.
Exane Derivatives first reported a position in Synchronoss Technologies in Q2 2015 and held it in 6 quarters.
Exane Derivatives's Synchronoss Technologies position peaked at $335K in Q2 2017.
26 funds tracked by Wall St. Rank held Synchronoss Technologies as of Q2 2018.

Based on Exane Derivatives's 13F filing for Q2 2018, filed 19 Jul 2018.